NINJ1 exerts a role in the development of preeclampsia through potential regulation by the Notch1 signaling pathway
Journal of Obstetrics and Gynaecology Research · 2025
DOI: 10.1111/jog.16295 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2025. Verfasst von Qin Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China. Hauptthemen laut MEDLINE: Pre-Eclampsia, Receptor, Notch1, Signal Transduction, Placenta. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Wuxi Medical Development Branch, Research project of Jiangsu Provincial Health Commission, Post-doctoral Foundation of the Affiliated Hospital of Nantong University.
Abstract (Originalsprache)
Aim
To explore NINJ1 expression in the placental tissue of preeclampsia patients, its correlation with patient status and pregnancy outcome, and offer preliminary insights into the relationship between NINJ1 and the Notch1 signaling pathway.
Methods
Placental tissue samples from PE and normal pregnancies were collected. NINJ1 expression was detected and compared between groups. Correlation with clinical data was analyzed. A PE cell model was established using hypoxia‐treated cells. The Notch pathway inhibitor DAPT was used. Additionally, trophoblast cells were treated with different concentrations of the Notch pathway inhibitor DAPT. The CCK‐8 assay and scratch test were used to assess cell proliferation and migration. The levels of NINJ1 and Notch signaling components were measured using qRT‐PCR and western blot.
Results
NINJ1 expression was higher in PE placental tissues compared to normal tissues. Women in the PE group had a higher incidence of hypoproteinemia, thoracoabdominal effusions, premature deliveries, and a higher hospitalization rate for newborns compared to the normal group. NINJ1 protein expression in the PE group placental tissues was negatively correlated with newborn birth weight and the serum albumin level and positively correlated with the 24‐h urinary protein and uric acid levels. NINJ1 expression was increased in trophoblast cells under hypoxic conditions, while Notch signaling pathway inhibition reduced the proliferation and migration abilities of trophoblast cells, downregulated Notch1, Hes1, and Hes5 protein expression, and significantly upregulated NINJ1 expression.
Conclusion
High expression of NINJ1 is associated with the occurrence of preeclampsia and adverse pregnancy outcomes, potentially regulated by the Notch1 signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
- Department of Obstetrics and Gynecology, Wendi Campus of Suizhou Central Hospital, Suizhou, Hubei, China.
- Department of Obstetrics and Gynecology, Affiliated Women's Hospital of Jiangnan University, Wuxi, Jiangsu, China.
ORCID-Profile: Qin Shi, Yunzhao Xu
Förderung
- Wuxi Medical Development Branch
- Research project of Jiangsu Provincial Health Commission
- Post-doctoral Foundation of the Affiliated Hospital of Nantong University
Zitieren
APA
Shi, Q., Gu, P., Tang, Y., Ma, Q., & Xu, Y. (2025). NINJ1 exerts a role in the development of preeclampsia through potential regulation by the Notch1 signaling pathway. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.16295
Vancouver
Shi Q, Gu P, Tang Y, Ma Q, Xu Y. NINJ1 exerts a role in the development of preeclampsia through potential regulation by the Notch1 signaling pathway. Journal of Obstetrics and Gynaecology Research. 2025. doi:10.1111/jog.16295
BibTeX
@article{Shi2025,
author = {Shi, Qin and Gu, Panyun and Tang, Yi and Ma, Qianqian and Xu, Yunzhao},
title = {NINJ1 exerts a role in the development of preeclampsia through potential regulation by the Notch1 signaling pathway},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2025},
doi = {10.1111/jog.16295}
}
EUVIMED